×
ADVERTISEMENT

small lymphocytic lymphoma

Statins May Improve Survival in Patients With CLL or SLL

A new study adds to the growing evidence that statins may have an anti-cancer effect. 

APRIL 23, 2025

Supportive Care and Other Tools for Managing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

In patients who received prior chronic lymphocytic leukemia/small lymphocytic lymphoma-directed therapy but require ...

MARCH 10, 2025

Breyanzi Approved for Adults With Relapsed/Refractory CLL or SLL

The FDA granted accelerated approval of lisocabtagene maraleucel (Breyanzi, Bristol Myers Squibb), a CD19-directed ...

MARCH 19, 2024

FDA Grants Accelerated Approval to Jaypirca for CLL and SLL

The FDA granted accelerated approval to pirtobrutinib (Jaypirca, Eli Lilly) for adults with chronic lymphocytic ...

DECEMBER 4, 2023

FDA Issues Warning on Duvelisib

The FDA is warning that results from a clinical trial show a possible increased risk for death with use of the PI3 ...

JULY 6, 2022

Load more